Stay updated with breaking news from Nasdaq Blue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bluebird bio (NASDAQ:BLUE – Get Free Report) had its price target cut by Wells Fargo & Company from $4.00 to $3.00 in a report released on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the biotechnology company’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 150.00% […]
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) were down 0.7% on Monday . The company traded as low as $1.35 and last traded at $1.36. Approximately 1,469,843 shares were traded during trading, a decline of 85% from the average daily volume of 9,802,114 shares. The stock had previously closed at $1.37. Analyst […]
Bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) saw a significant increase in short interest in January. As of January 15th, there was short interest totalling 26,570,000 shares, an increase of 10.3% from the December 31st total of 24,090,000 shares. Based on an average daily trading volume, of 11,100,000 shares, the short-interest ratio is currently […]
Bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 24,090,000 shares, a decline of 5.4% from the December 15th total of 25,470,000 shares. Based on an average daily volume of 10,240,000 shares, the days-to-cover ratio […]
Shares of bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) have been assigned a consensus recommendation of “Hold” from the thirteen research firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating […]